Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
"As use of this medication is extended and expanded for weight loss and other health advocacy, there is an opportunity to do much more, including product development, packaging, online and in-store merchandising, education, and promotion." Opportunities include: Merchandise dietary and nutritional support items near the pharmacy in drug and grocery, improving the shopping experience for consumers taking GLP-1s Understand that 91% of Millennials, 90% of Gen Z, and 64% of Gen X on GLP-1 medications are interested in packaged foods that support their weight loss goals, and they want messaging called out on the package Meet consumers where they are with product and health information, amplifying digital commerce programming Advance opportunities on retailer apps and websites to support these shoppers Acosta Group's "GLP-1 & The Weight Loss Revolution Shopper Insights Study" was conducted Feb
Drug misuse* involves taking a drug for nonmedical purposes, or in a way thats not approved
A deliberate approachtracking stakes, outcomes, and session lengthbuilds a clearer picture of performance without chasing losses or overreacting to short-term variance
Influencers post dramatic before-and-after photos
Yabe D, Nakamura J, Kaneto H et al (2020) Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial
Do not take if pregnant or lactating
%20(1).png)
